Relapsed/Refractory Multiple Myeloma: Essential Strategies to Optimize the Utility of Novel and Cellular Therapies

Relapsed/Refractory Multiple Myeloma: Essential Strategies to Optimize the Utility of Novel and Cellular Therapies

Describe the mechanisms, clinical rationale, and most recent data associated with novel and emerging therapies for R/R MM Evaluate the most current guidelines for the management of R/R MM, including considerations for treatment selection and AE management Implement multidisciplinary team strategies and real-world clinical data into clinical practice to improve patient care coordination and overall outcomes

  • Provider:HMP Education
  • Activity Link: https://hmpeducation.com/program/2024-gduhem-106
  • Start Date: 2024-08-29 05:00:00
  • End Date: 2024-08-29 05:00:00
  • Credit Details: AAPA Category 1 Credit™️: 0.75 hours
    AMA PRA Category 1 Credit™️: 0.75 hours
    Nursing: 0.75 hours
    Pharmacy: 0.75 hours
  • MOC Credit Details: ABS - 0.75 Point; Credit Type(s): Accredited CME (ABS)
  • Commercial Support: Source: Janssen (Any division) - Amount: 0 - Is Kind Support: False
  • Activity Type: Enduring Material
  • CME Finder Type: Online Learning
  • Fee to Participate: No, it's free
  • Measured Outcome: Learner Knowledge, Learner/Team Competence
  • Provider Ship: Directly Provided
  • Registration: Open to all
  • Specialty: General Surgery
«
»
Subscribe
Notify of
guest
0 Comments
Oldest
Newest Most Voted
Inline Feedbacks
View all comments
0
Would love your thoughts, please comment.x
()
x

Contact us

If you want to join leaders who will shape what Americans think about sleep.

Name(Required)
Sign Up
This field is for validation purposes and should be left unchanged.

Sign up for the expert list

for media inquiries

Name(Required)
Sign Up
This field is for validation purposes and should be left unchanged.